Connect Biopharma Holdings Limited

NasdaqGM:CNTB Stock Report

Market Cap: US$82.1m

Connect Biopharma Holdings Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Barry Quart

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenure2.6yrs
Board average tenure3.4yrs

Recent management updates

Recent updates

Companies Like Connect Biopharma Holdings (NASDAQ:CNTB) Are In A Position To Invest In Growth

Mar 07
Companies Like Connect Biopharma Holdings (NASDAQ:CNTB) Are In A Position To Invest In Growth

Is Connect Biopharma Holdings (NASDAQ:CNTB) In A Good Position To Invest In Growth?

Sep 19
Is Connect Biopharma Holdings (NASDAQ:CNTB) In A Good Position To Invest In Growth?

Will Connect Biopharma Holdings (NASDAQ:CNTB) Spend Its Cash Wisely?

Mar 29
Will Connect Biopharma Holdings (NASDAQ:CNTB) Spend Its Cash Wisely?

Is Connect Biopharma Holdings (NASDAQ:CNTB) In A Good Position To Deliver On Growth Plans?

Dec 14
Is Connect Biopharma Holdings (NASDAQ:CNTB) In A Good Position To Deliver On Growth Plans?

Market Appears To Relegate Connect Biopharma To A Long-Term Hold

Oct 10

Connect Biopharma Is A Sleeper Heading Into October Data Readout

Sep 26

Connect Biopharma reports 1H results

Sep 13

We're Keeping An Eye On Connect Biopharma Holdings' (NASDAQ:CNTB) Cash Burn Rate

Aug 12
We're Keeping An Eye On Connect Biopharma Holdings' (NASDAQ:CNTB) Cash Burn Rate

We're Keeping An Eye On Connect Biopharma Holdings' (NASDAQ:CNTB) Cash Burn Rate

Apr 29
We're Keeping An Eye On Connect Biopharma Holdings' (NASDAQ:CNTB) Cash Burn Rate

Connect Biopharma's Latest Dermatitis Drug Update Fails To Pump Up Shares

Jan 12

We're Hopeful That Connect Biopharma Holdings (NASDAQ:CNTB) Will Use Its Cash Wisely

Jan 01
We're Hopeful That Connect Biopharma Holdings (NASDAQ:CNTB) Will Use Its Cash Wisely

CEO

Barry Quart (67 yo)

no data

Tenure

Dr. Barry D. Quart, Pharm D., serves as Chief Executive Officer & Director of Connect Biopharma Holdings Limited since June 12, 2024. He had served as Chief Executive Officer of Heron Therapeutics, Inc. si...


Leadership Team

NamePositionTenureCompensationOwnership
Zheng Wei
Co-Founder & Director12.4yrsno data10.76%
$ 8.8m
Wubin Pan
Co-Founder & Directorno datano data11.25%
$ 9.2m
Steven Chan
Chief Financial Officer2.6yrsno data0.014%
$ 11.2k
Barry Quart
CEO & Directorno datano datano data
David Szekeres
Presidentno datano datano data
Jiang Bian
General Counsel & Chief Compliance Officer2.8yrsno datano data
Lei Sun
VP of Biologics & Head of CMC4.4yrsno datano data
Raul Collazo
VP & Global Head of Medical Affairsno datano datano data
Srikanth Pendyala
Senior Vice President of Clinical Development(Consultant)less than a yearno datano data

2.6yrs

Average Tenure

59.5yo

Average Age

Experienced Management: CNTB's management team is considered experienced (2.6 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Zheng Wei
Co-Founder & Director12.4yrsno data10.76%
$ 8.8m
Wubin Pan
Co-Founder & Director12.1yrsno data11.25%
$ 9.2m
Barry Quart
CEO & Directorno datano datano data
Stuart J. Swiedler
Member of Scientific Advisory Board3.4yrsno datano data
Jean I. Liu
Independent Director2.8yrsno data0%
$ 0
Karen Wilson
Independent Non-Executive Director3.5yrsno data0.018%
$ 14.9k
Kleanthis Xanthopoulos
Independent Chairman3.5yrsno data0%
$ 0
Brian Gordon Feagan
Member of Scientific Advisory Board3.4yrsno datano data
David T. Rubin
Member of Scientific Advisory Board3.4yrsno datano data
Emma Guttman-Yassky
Member of Scientific Advisory Board3.4yrsno datano data
Kan Chen
Independent Non-Executive Director3.5yrsno datano data
Edward M. Kerwin
Member of Scientific Advisory Board3.4yrsno datano data

3.4yrs

Average Tenure

60.5yo

Average Age

Experienced Board: CNTB's board of directors are considered experienced (3.4 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.